Medical Care

Global Production of Lentiviral Vectors Market Research Report 2025

The global market for Production of Lentiviral Vectors was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Lentiviruses are a subclass of retroviruses, but unlike other retroviruses, lentiviruses can integrate into the genome of non-dividing cells. As retroviral vectors, lentiviral vectors never contain genes for replication. Therefore, production of lentivirus requires propagation in packaging cell lines (e.g., HEK293 cells transfected with plasmids encoding virion proteins). The Lentiviral Production System is an early optimized system that provides a scalable, high-throughput lentiviral vector production platform. Compared with retroviral vectors produced in stable cell lines, clinical-grade lentiviruses are mostly produced by transient transfection of 293 or 293T cells in cell factories. However, recent advances have favored the use of hollow fiber tube reactors, suspension culture, and improved stable cell line production.
North American market for Production of Lentiviral Vectors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Production of Lentiviral Vectors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Production of Lentiviral Vectors in Pharmaceutical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Production of Lentiviral Vectors include Thermo Fisher Scientific, Oxgene, Lonza, Charles River, Merck, Oxford Biomedica, AGC Biologics（MolMed）, GeneMedi, OriGene, Invitria, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Production of Lentiviral Vectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Production of Lentiviral Vectors.
The Production of Lentiviral Vectors market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Production of Lentiviral Vectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Production of Lentiviral Vectors companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Oxgene
Lonza
Charles River
Merck
Oxford Biomedica
AGC Biologics（MolMed）
GeneMedi
OriGene
Invitria
Polyplus (Sartorius)
Kerafast
CCRM
SignaGen Laboratories
Cellomics Technology
FUJIFILM Diosynth Biotechnologies
Biovian
Miltenyi Bioindustry
Gene Universal
Aldevron
Takara Bio
Gentarget
Bluebird Bio
EurekaBio
Obio Technology
WuXi ATU
GenScript ProBio
Segment by Type
Transient Transfection
Stable Cell Lines
Others
Segment by Application
Pharmaceutical
Medical
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Production of Lentiviral Vectors company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Production of Lentiviral Vectors Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Transient Transfection
1.2.3 Stable Cell Lines
1.2.4 Others
1.3 Market by Application
1.3.1 Global Production of Lentiviral Vectors Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Medical
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Production of Lentiviral Vectors Market Perspective (2020-2031)
2.2 Global Production of Lentiviral Vectors Growth Trends by Region
2.2.1 Global Production of Lentiviral Vectors Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Production of Lentiviral Vectors Historic Market Size by Region (2020-2025)
2.2.3 Production of Lentiviral Vectors Forecasted Market Size by Region (2026-2031)
2.3 Production of Lentiviral Vectors Market Dynamics
2.3.1 Production of Lentiviral Vectors Industry Trends
2.3.2 Production of Lentiviral Vectors Market Drivers
2.3.3 Production of Lentiviral Vectors Market Challenges
2.3.4 Production of Lentiviral Vectors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Production of Lentiviral Vectors Players by Revenue
3.1.1 Global Top Production of Lentiviral Vectors Players by Revenue (2020-2025)
3.1.2 Global Production of Lentiviral Vectors Revenue Market Share by Players (2020-2025)
3.2 Global Production of Lentiviral Vectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Production of Lentiviral Vectors Revenue
3.4 Global Production of Lentiviral Vectors Market Concentration Ratio
3.4.1 Global Production of Lentiviral Vectors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Production of Lentiviral Vectors Revenue in 2024
3.5 Global Key Players of Production of Lentiviral Vectors Head office and Area Served
3.6 Global Key Players of Production of Lentiviral Vectors, Product and Application
3.7 Global Key Players of Production of Lentiviral Vectors, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Production of Lentiviral Vectors Breakdown Data by Type
4.1 Global Production of Lentiviral Vectors Historic Market Size by Type (2020-2025)
4.2 Global Production of Lentiviral Vectors Forecasted Market Size by Type (2026-2031)
5 Production of Lentiviral Vectors Breakdown Data by Application
5.1 Global Production of Lentiviral Vectors Historic Market Size by Application (2020-2025)
5.2 Global Production of Lentiviral Vectors Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Production of Lentiviral Vectors Market Size (2020-2031)
6.2 North America Production of Lentiviral Vectors Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Production of Lentiviral Vectors Market Size by Country (2020-2025)
6.4 North America Production of Lentiviral Vectors Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Production of Lentiviral Vectors Market Size (2020-2031)
7.2 Europe Production of Lentiviral Vectors Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Production of Lentiviral Vectors Market Size by Country (2020-2025)
7.4 Europe Production of Lentiviral Vectors Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Production of Lentiviral Vectors Market Size (2020-2031)
8.2 Asia-Pacific Production of Lentiviral Vectors Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Production of Lentiviral Vectors Market Size by Region (2020-2025)
8.4 Asia-Pacific Production of Lentiviral Vectors Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Production of Lentiviral Vectors Market Size (2020-2031)
9.2 Latin America Production of Lentiviral Vectors Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Production of Lentiviral Vectors Market Size by Country (2020-2025)
9.4 Latin America Production of Lentiviral Vectors Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Production of Lentiviral Vectors Market Size (2020-2031)
10.2 Middle East & Africa Production of Lentiviral Vectors Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Production of Lentiviral Vectors Market Size by Country (2020-2025)
10.4 Middle East & Africa Production of Lentiviral Vectors Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Production of Lentiviral Vectors Introduction
11.1.4 Thermo Fisher Scientific Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Oxgene
11.2.1 Oxgene Company Details
11.2.2 Oxgene Business Overview
11.2.3 Oxgene Production of Lentiviral Vectors Introduction
11.2.4 Oxgene Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.2.5 Oxgene Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Production of Lentiviral Vectors Introduction
11.3.4 Lonza Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.3.5 Lonza Recent Development
11.4 Charles River
11.4.1 Charles River Company Details
11.4.2 Charles River Business Overview
11.4.3 Charles River Production of Lentiviral Vectors Introduction
11.4.4 Charles River Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.4.5 Charles River Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Production of Lentiviral Vectors Introduction
11.5.4 Merck Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.5.5 Merck Recent Development
11.6 Oxford Biomedica
11.6.1 Oxford Biomedica Company Details
11.6.2 Oxford Biomedica Business Overview
11.6.3 Oxford Biomedica Production of Lentiviral Vectors Introduction
11.6.4 Oxford Biomedica Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.6.5 Oxford Biomedica Recent Development
11.7 AGC Biologics（MolMed）
11.7.1 AGC Biologics（MolMed） Company Details
11.7.2 AGC Biologics（MolMed） Business Overview
11.7.3 AGC Biologics（MolMed） Production of Lentiviral Vectors Introduction
11.7.4 AGC Biologics（MolMed） Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.7.5 AGC Biologics（MolMed） Recent Development
11.8 GeneMedi
11.8.1 GeneMedi Company Details
11.8.2 GeneMedi Business Overview
11.8.3 GeneMedi Production of Lentiviral Vectors Introduction
11.8.4 GeneMedi Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.8.5 GeneMedi Recent Development
11.9 OriGene
11.9.1 OriGene Company Details
11.9.2 OriGene Business Overview
11.9.3 OriGene Production of Lentiviral Vectors Introduction
11.9.4 OriGene Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.9.5 OriGene Recent Development
11.10 Invitria
11.10.1 Invitria Company Details
11.10.2 Invitria Business Overview
11.10.3 Invitria Production of Lentiviral Vectors Introduction
11.10.4 Invitria Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.10.5 Invitria Recent Development
11.11 Polyplus (Sartorius)
11.11.1 Polyplus (Sartorius) Company Details
11.11.2 Polyplus (Sartorius) Business Overview
11.11.3 Polyplus (Sartorius) Production of Lentiviral Vectors Introduction
11.11.4 Polyplus (Sartorius) Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.11.5 Polyplus (Sartorius) Recent Development
11.12 Kerafast
11.12.1 Kerafast Company Details
11.12.2 Kerafast Business Overview
11.12.3 Kerafast Production of Lentiviral Vectors Introduction
11.12.4 Kerafast Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.12.5 Kerafast Recent Development
11.13 CCRM
11.13.1 CCRM Company Details
11.13.2 CCRM Business Overview
11.13.3 CCRM Production of Lentiviral Vectors Introduction
11.13.4 CCRM Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.13.5 CCRM Recent Development
11.14 SignaGen Laboratories
11.14.1 SignaGen Laboratories Company Details
11.14.2 SignaGen Laboratories Business Overview
11.14.3 SignaGen Laboratories Production of Lentiviral Vectors Introduction
11.14.4 SignaGen Laboratories Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.14.5 SignaGen Laboratories Recent Development
11.15 Cellomics Technology
11.15.1 Cellomics Technology Company Details
11.15.2 Cellomics Technology Business Overview
11.15.3 Cellomics Technology Production of Lentiviral Vectors Introduction
11.15.4 Cellomics Technology Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.15.5 Cellomics Technology Recent Development
11.16 FUJIFILM Diosynth Biotechnologies
11.16.1 FUJIFILM Diosynth Biotechnologies Company Details
11.16.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.16.3 FUJIFILM Diosynth Biotechnologies Production of Lentiviral Vectors Introduction
11.16.4 FUJIFILM Diosynth Biotechnologies Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.16.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.17 Biovian
11.17.1 Biovian Company Details
11.17.2 Biovian Business Overview
11.17.3 Biovian Production of Lentiviral Vectors Introduction
11.17.4 Biovian Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.17.5 Biovian Recent Development
11.18 Miltenyi Bioindustry
11.18.1 Miltenyi Bioindustry Company Details
11.18.2 Miltenyi Bioindustry Business Overview
11.18.3 Miltenyi Bioindustry Production of Lentiviral Vectors Introduction
11.18.4 Miltenyi Bioindustry Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.18.5 Miltenyi Bioindustry Recent Development
11.19 Gene Universal
11.19.1 Gene Universal Company Details
11.19.2 Gene Universal Business Overview
11.19.3 Gene Universal Production of Lentiviral Vectors Introduction
11.19.4 Gene Universal Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.19.5 Gene Universal Recent Development
11.20 Aldevron
11.20.1 Aldevron Company Details
11.20.2 Aldevron Business Overview
11.20.3 Aldevron Production of Lentiviral Vectors Introduction
11.20.4 Aldevron Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.20.5 Aldevron Recent Development
11.21 Takara Bio
11.21.1 Takara Bio Company Details
11.21.2 Takara Bio Business Overview
11.21.3 Takara Bio Production of Lentiviral Vectors Introduction
11.21.4 Takara Bio Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.21.5 Takara Bio Recent Development
11.22 Gentarget
11.22.1 Gentarget Company Details
11.22.2 Gentarget Business Overview
11.22.3 Gentarget Production of Lentiviral Vectors Introduction
11.22.4 Gentarget Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.22.5 Gentarget Recent Development
11.23 Bluebird Bio
11.23.1 Bluebird Bio Company Details
11.23.2 Bluebird Bio Business Overview
11.23.3 Bluebird Bio Production of Lentiviral Vectors Introduction
11.23.4 Bluebird Bio Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.23.5 Bluebird Bio Recent Development
11.24 EurekaBio
11.24.1 EurekaBio Company Details
11.24.2 EurekaBio Business Overview
11.24.3 EurekaBio Production of Lentiviral Vectors Introduction
11.24.4 EurekaBio Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.24.5 EurekaBio Recent Development
11.25 Obio Technology
11.25.1 Obio Technology Company Details
11.25.2 Obio Technology Business Overview
11.25.3 Obio Technology Production of Lentiviral Vectors Introduction
11.25.4 Obio Technology Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.25.5 Obio Technology Recent Development
11.26 WuXi ATU
11.26.1 WuXi ATU Company Details
11.26.2 WuXi ATU Business Overview
11.26.3 WuXi ATU Production of Lentiviral Vectors Introduction
11.26.4 WuXi ATU Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.26.5 WuXi ATU Recent Development
11.27 GenScript ProBio
11.27.1 GenScript ProBio Company Details
11.27.2 GenScript ProBio Business Overview
11.27.3 GenScript ProBio Production of Lentiviral Vectors Introduction
11.27.4 GenScript ProBio Revenue in Production of Lentiviral Vectors Business (2020-2025)
11.27.5 GenScript ProBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Production of Lentiviral Vectors Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Transient Transfection
Table 3. Key Players of Stable Cell Lines
Table 4. Key Players of Others
Table 5. Global Production of Lentiviral Vectors Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Production of Lentiviral Vectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Production of Lentiviral Vectors Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Production of Lentiviral Vectors Market Share by Region (2020-2025)
Table 9. Global Production of Lentiviral Vectors Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Production of Lentiviral Vectors Market Share by Region (2026-2031)
Table 11. Production of Lentiviral Vectors Market Trends
Table 12. Production of Lentiviral Vectors Market Drivers
Table 13. Production of Lentiviral Vectors Market Challenges
Table 14. Production of Lentiviral Vectors Market Restraints
Table 15. Global Production of Lentiviral Vectors Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Production of Lentiviral Vectors Market Share by Players (2020-2025)
Table 17. Global Top Production of Lentiviral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Production of Lentiviral Vectors as of 2024)
Table 18. Ranking of Global Top Production of Lentiviral Vectors Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Production of Lentiviral Vectors Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Production of Lentiviral Vectors, Headquarters and Area Served
Table 21. Global Key Players of Production of Lentiviral Vectors, Product and Application
Table 22. Global Key Players of Production of Lentiviral Vectors, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Production of Lentiviral Vectors Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Production of Lentiviral Vectors Revenue Market Share by Type (2020-2025)
Table 26. Global Production of Lentiviral Vectors Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Production of Lentiviral Vectors Revenue Market Share by Type (2026-2031)
Table 28. Global Production of Lentiviral Vectors Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Production of Lentiviral Vectors Revenue Market Share by Application (2020-2025)
Table 30. Global Production of Lentiviral Vectors Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Production of Lentiviral Vectors Revenue Market Share by Application (2026-2031)
Table 32. North America Production of Lentiviral Vectors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Production of Lentiviral Vectors Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Production of Lentiviral Vectors Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Production of Lentiviral Vectors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Production of Lentiviral Vectors Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Production of Lentiviral Vectors Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Production of Lentiviral Vectors Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Production of Lentiviral Vectors Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Production of Lentiviral Vectors Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Production of Lentiviral Vectors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Production of Lentiviral Vectors Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Production of Lentiviral Vectors Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Production of Lentiviral Vectors Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Production of Lentiviral Vectors Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Production of Lentiviral Vectors Market Size by Country (2026-2031) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Details
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific Production of Lentiviral Vectors Product
Table 50. Thermo Fisher Scientific Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. Oxgene Company Details
Table 53. Oxgene Business Overview
Table 54. Oxgene Production of Lentiviral Vectors Product
Table 55. Oxgene Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 56. Oxgene Recent Development
Table 57. Lonza Company Details
Table 58. Lonza Business Overview
Table 59. Lonza Production of Lentiviral Vectors Product
Table 60. Lonza Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 61. Lonza Recent Development
Table 62. Charles River Company Details
Table 63. Charles River Business Overview
Table 64. Charles River Production of Lentiviral Vectors Product
Table 65. Charles River Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 66. Charles River Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Production of Lentiviral Vectors Product
Table 70. Merck Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Oxford Biomedica Company Details
Table 73. Oxford Biomedica Business Overview
Table 74. Oxford Biomedica Production of Lentiviral Vectors Product
Table 75. Oxford Biomedica Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 76. Oxford Biomedica Recent Development
Table 77. AGC Biologics（MolMed） Company Details
Table 78. AGC Biologics（MolMed） Business Overview
Table 79. AGC Biologics（MolMed） Production of Lentiviral Vectors Product
Table 80. AGC Biologics（MolMed） Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 81. AGC Biologics（MolMed） Recent Development
Table 82. GeneMedi Company Details
Table 83. GeneMedi Business Overview
Table 84. GeneMedi Production of Lentiviral Vectors Product
Table 85. GeneMedi Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 86. GeneMedi Recent Development
Table 87. OriGene Company Details
Table 88. OriGene Business Overview
Table 89. OriGene Production of Lentiviral Vectors Product
Table 90. OriGene Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 91. OriGene Recent Development
Table 92. Invitria Company Details
Table 93. Invitria Business Overview
Table 94. Invitria Production of Lentiviral Vectors Product
Table 95. Invitria Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 96. Invitria Recent Development
Table 97. Polyplus (Sartorius) Company Details
Table 98. Polyplus (Sartorius) Business Overview
Table 99. Polyplus (Sartorius) Production of Lentiviral Vectors Product
Table 100. Polyplus (Sartorius) Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 101. Polyplus (Sartorius) Recent Development
Table 102. Kerafast Company Details
Table 103. Kerafast Business Overview
Table 104. Kerafast Production of Lentiviral Vectors Product
Table 105. Kerafast Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 106. Kerafast Recent Development
Table 107. CCRM Company Details
Table 108. CCRM Business Overview
Table 109. CCRM Production of Lentiviral Vectors Product
Table 110. CCRM Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 111. CCRM Recent Development
Table 112. SignaGen Laboratories Company Details
Table 113. SignaGen Laboratories Business Overview
Table 114. SignaGen Laboratories Production of Lentiviral Vectors Product
Table 115. SignaGen Laboratories Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 116. SignaGen Laboratories Recent Development
Table 117. Cellomics Technology Company Details
Table 118. Cellomics Technology Business Overview
Table 119. Cellomics Technology Production of Lentiviral Vectors Product
Table 120. Cellomics Technology Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 121. Cellomics Technology Recent Development
Table 122. FUJIFILM Diosynth Biotechnologies Company Details
Table 123. FUJIFILM Diosynth Biotechnologies Business Overview
Table 124. FUJIFILM Diosynth Biotechnologies Production of Lentiviral Vectors Product
Table 125. FUJIFILM Diosynth Biotechnologies Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 126. FUJIFILM Diosynth Biotechnologies Recent Development
Table 127. Biovian Company Details
Table 128. Biovian Business Overview
Table 129. Biovian Production of Lentiviral Vectors Product
Table 130. Biovian Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 131. Biovian Recent Development
Table 132. Miltenyi Bioindustry Company Details
Table 133. Miltenyi Bioindustry Business Overview
Table 134. Miltenyi Bioindustry Production of Lentiviral Vectors Product
Table 135. Miltenyi Bioindustry Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 136. Miltenyi Bioindustry Recent Development
Table 137. Gene Universal Company Details
Table 138. Gene Universal Business Overview
Table 139. Gene Universal Production of Lentiviral Vectors Product
Table 140. Gene Universal Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 141. Gene Universal Recent Development
Table 142. Aldevron Company Details
Table 143. Aldevron Business Overview
Table 144. Aldevron Production of Lentiviral Vectors Product
Table 145. Aldevron Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 146. Aldevron Recent Development
Table 147. Takara Bio Company Details
Table 148. Takara Bio Business Overview
Table 149. Takara Bio Production of Lentiviral Vectors Product
Table 150. Takara Bio Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 151. Takara Bio Recent Development
Table 152. Gentarget Company Details
Table 153. Gentarget Business Overview
Table 154. Gentarget Production of Lentiviral Vectors Product
Table 155. Gentarget Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 156. Gentarget Recent Development
Table 157. Bluebird Bio Company Details
Table 158. Bluebird Bio Business Overview
Table 159. Bluebird Bio Production of Lentiviral Vectors Product
Table 160. Bluebird Bio Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 161. Bluebird Bio Recent Development
Table 162. EurekaBio Company Details
Table 163. EurekaBio Business Overview
Table 164. EurekaBio Production of Lentiviral Vectors Product
Table 165. EurekaBio Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 166. EurekaBio Recent Development
Table 167. Obio Technology Company Details
Table 168. Obio Technology Business Overview
Table 169. Obio Technology Production of Lentiviral Vectors Product
Table 170. Obio Technology Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 171. Obio Technology Recent Development
Table 172. WuXi ATU Company Details
Table 173. WuXi ATU Business Overview
Table 174. WuXi ATU Production of Lentiviral Vectors Product
Table 175. WuXi ATU Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 176. WuXi ATU Recent Development
Table 177. GenScript ProBio Company Details
Table 178. GenScript ProBio Business Overview
Table 179. GenScript ProBio Production of Lentiviral Vectors Product
Table 180. GenScript ProBio Revenue in Production of Lentiviral Vectors Business (2020-2025) & (US$ Million)
Table 181. GenScript ProBio Recent Development
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
Table 185. Authors List of This Report


List of Figures
Figure 1. Production of Lentiviral Vectors Picture
Figure 2. Global Production of Lentiviral Vectors Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Production of Lentiviral Vectors Market Share by Type: 2024 VS 2031
Figure 4. Transient Transfection Features
Figure 5. Stable Cell Lines Features
Figure 6. Others Features
Figure 7. Global Production of Lentiviral Vectors Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Production of Lentiviral Vectors Market Share by Application: 2024 VS 2031
Figure 9. Pharmaceutical Case Studies
Figure 10. Medical Case Studies
Figure 11. Others Case Studies
Figure 12. Production of Lentiviral Vectors Report Years Considered
Figure 13. Global Production of Lentiviral Vectors Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Production of Lentiviral Vectors Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Production of Lentiviral Vectors Market Share by Region: 2024 VS 2031
Figure 16. Global Production of Lentiviral Vectors Market Share by Players in 2024
Figure 17. Global Top Production of Lentiviral Vectors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Production of Lentiviral Vectors as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Production of Lentiviral Vectors Revenue in 2024
Figure 19. North America Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Production of Lentiviral Vectors Market Share by Country (2020-2031)
Figure 21. United States Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Production of Lentiviral Vectors Market Share by Country (2020-2031)
Figure 25. Germany Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Production of Lentiviral Vectors Market Share by Region (2020-2031)
Figure 33. China Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Production of Lentiviral Vectors Market Share by Country (2020-2031)
Figure 41. Mexico Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Production of Lentiviral Vectors Market Share by Country (2020-2031)
Figure 45. Turkey Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Production of Lentiviral Vectors Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 49. Oxgene Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 50. Lonza Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 51. Charles River Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 52. Merck Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 53. Oxford Biomedica Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 54. AGC Biologics（MolMed） Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 55. GeneMedi Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 56. OriGene Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 57. Invitria Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 58. Polyplus (Sartorius) Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 59. Kerafast Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 60. CCRM Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 61. SignaGen Laboratories Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 62. Cellomics Technology Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 63. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 64. Biovian Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 65. Miltenyi Bioindustry Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 66. Gene Universal Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 67. Aldevron Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 68. Takara Bio Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 69. Gentarget Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 70. Bluebird Bio Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 71. EurekaBio Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 72. Obio Technology Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 73. WuXi ATU Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 74. GenScript ProBio Revenue Growth Rate in Production of Lentiviral Vectors Business (2020-2025)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies